FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Poll|November 15, 2013
Vaccine-Preventable Infection?
Author(s)Robert P. Blereau, MD
From lacy and reticular and limited to the cheeks, this rash quickly covered the child’s body and transformed into a solid rash. Your dx?
Advertisement
A 5-year-old boy presented with an asymptomatic lacy, reticular rash of 4-days duration. It began with the appearance of a solid red rash on his cheeks. The next day the lacy rash covered his entire body and the solid rash on his cheeks also became lacy.
What's your diagnosis?
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Insulin Efsitora Alfa-Gobe for Adults With Type 2 Diabetes
2
Individualizing Obesity Treatment in Primary Care: An Expert Discussion
3
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
4
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
5